Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
2021; American Association for the Advancement of Science; Volume: 13; Issue: 601 Linguagem: Inglês
10.1126/scitranslmed.abh3826
ISSN1946-6242
AutoresHeather Kalish, Carleen Klumpp‐Thomas, Sally Hunsberger, Holly Ann Baus, Michael P. Fay, Nalyn Siripong, Jing Wang, Jennifer Hicks, Jennifer Mehalko, Jameson Travers, Matthew Drew, Kyle Pauly, Jacquelyn Spathies, Tran B. Ngo, Kenneth M. Adusei, Maria Karkanitsa, Jennifer A. Croker, Yan Li, Barry I. Graubard, Lindsay Czajkowski, Olivia Belliveau, Cheryl Chairez, Kelly Snead, Peter Frank, Anandakumar Shunmugavel, Alison Han, Luca T. Giurgea, Luz Angela Rosas, Rachel Bean, Rani Athota, Adriana Cervantes-Medina, Monica Gouzoulis, Brittany Heffelfinger, Shannon Valenti, Rocco Caldararo, Michelle M. Kolberg, Andrew P. Kelly, Reid Simon, Saifullah Shafiq, Vanessa Wall, Susan Reed, Eric W. Ford, Ravi Lokwani, John-Paul Denson, Simon Messing, Sam Michael, William Gillette, Robert P. Kimberly, Steven E. Reís, Matthew D. Hall, Dominic Esposito, Matthew J. Memoli, Kaitlyn Sadtler,
Tópico(s)Dermatological and COVID-19 studies
Resumo16.8 million SARS-CoV-2 infections in the US went undiagnosed in the first 6 months of the pandemic compared to 3.5 million diagnosed infections.
Referência(s)